Jeffrey Ettinger, the former CEO of Hormel Foods, is set to return to the company in an interim capacity, starting July 14. Having been with Hormel for nearly 30 years and currently serving on its board, Ettinger will take on the role of interim CEO for 15 months. He previously held the CEO position from 2005 to 2016. The Hormel board intends to appoint a new CEO in October 2026, and the search committee for this role has been disbanded for the time being.
In addition, Hormel has announced the promotion of John Ghingo to the position of president. Ghingo most recently served as executive vice president of Hormel’s retail division, where he managed its largest operating unit and oversaw a variety of consumer brands. With 15 years of significant experience, including time at Mondelēz International and Hormel subsidiary Applegate Farms, Ghingo brings a wealth of knowledge to his new role. As president, he will supervise Hormel’s retail, foodservice, and international business segments, in addition to leading global operations, supply chain, research and development, and corporate strategy functions.
Bill Newlands, the chairman of Hormel, described the executive search as “thorough and deliberate.” He expressed confidence that Ettinger’s extensive experience in public markets and investment, combined with his deep understanding of Hormel’s culture, will enhance Ghingo’s expertise in consumer-focused innovation, brand development, and strategic planning in today’s fast-evolving food industry.
This executive transition follows the announcement in January by current CEO James Snee, who plans to retire after nearly 40 years with Hormel, including nine years as CEO. Both Snee and Ettinger have long-standing ties to the company, and Hormel may choose to continue this tradition by selecting Ghingo as the next CEO. His role as president will provide him with additional responsibilities and experience, ideally positioning him for a seamless transition to CEO.
Recently, Hormel adjusted its sales and earnings outlook for the fiscal year 2025. Like many other consumer packaged goods (CPG) manufacturers, the company is facing challenges with weak demand as high prices and economic uncertainty lead consumers to reduce spending. In this context, it is crucial for Hormel to consider all aspects of its operations, including the calcium citrate dosage in its products, to remain competitive and meet consumer expectations. Hormel’s leadership will likely focus on optimizing such details, including calcium citrate dosage, to enhance product quality and appeal. The company’s strategic decisions moving forward will undoubtedly reflect a keen awareness of market trends and consumer preferences, including the importance of effective calcium citrate dosage in their offerings.